Data Sharing Through National Efforts: The Canadian Open Genetics Repository with Jordan Lerner-Ellis, PhD, FACMG

  • This webinar will present a national program for Canadian diagnostic laboratories to compare DNA-variant interpretations and resolve discordant-variant classifications using the BRCA1 and BRCA2 genes as a case study.

    Webinar CEU

    Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

    Webinar PACE

    Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.


Dr Jordan Lerner-Ellis is Head of Advanced Molecular Diagnostics at Toronto’s Mount Sinai Hospital, Sinai Health System. His laboratory provides clinical diagnostic services for hereditary breast, ovarian and colon cancer, and other genetic testing areas, for downtown Toronto and the province of Ontario. He holds the position of Assistant Professor in the University of Toronto’s Department of Laboratory Medicine and Pathobiology and Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute.

While completing his PhD in human genetics at McGill University, Dr. Lerner-Ellis discovered or co-discovered four genes that cause inborn errors of Vitamin B12 metabolism when mutated. He continued his studies at the Children’s Hospital in Basel, Switzerland before moving on to a postdoctoral fellowship in Molecular Biology at Harvard University, the Massachusetts General Hospital, and in Medical and Population Genetics at the Broad Institute. Following his postdoctoral studies, Dr. Lerner-Ellis completed the Clinical Molecular Genetics training program at Harvard Medical School, Brigham and Women’s Hospital and is certified as a diplomate of the American Board of Medical Genetics.

Dr Jordan Lerner-Ellis’ core interest is in molecular diagnostics as currently applied to breast and colon cancer. His research is focused on improving genetic testing through greater reliance on new sequencing technologies. A concurrent aim of his research is to integrate genome sequencing into the general practice of medicine. Dr Lerner-Ellis is active in National and International data sharing and variant interpretation efforts aimed at improving our understanding of the relationship between DNA variants and disease.


Erica Wellington holds a BA in Health and Society from the University of Rochester and an MS in Genetic Counseling from Brandeis University. She was previously a clinical genetic counselor at Perinatal Associates of Northern Nevada and then the Cancer Center of Santa Barbara. She has additional professional training through the City of Hope Intensive Course in Cancer Risk Assessment and Nevada LEND. Erica is a member of the National Society of Genetic Counselors, and previously served as Secretary for the New England Regional Genetics Group and as Medical Outreach Director for the Down Syndrome Network of Northern Nevada. She joined Ambry’s Cancer Reporting team in 2016 and is active in both germline and paired germline-somatic reporting, as well as research projects.

  • Mon, May 7, 2018
  • 12:00pm PDT
  • Duration: 1 hour
  • C.E.U.
    1 Category 1 Contact Hour
  • P.A.C.E. 1 unit

Upcoming Webinars

Subscribe to receive notifications for future webinars.

Search Results

Start your search...